Sentinel lymph node biopsy

Let’s get back to basics in managing melanoma

BMJ 2008; 336 doi: 10.1136/bmj.39568.466910.80 (Published 8 May 2008)
Cite this as: BMJ 2008;336:1033.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Anthony Dixon, censor
  1. 1Australasian College of Skin Cancer Medicine, Geelong, VIC 3216, Australia
  1. anthony{at}skincanceronly.com

    I find the debate about sentinel node biopsy puzzling.1 Clinicians are getting bogged down with this question while the fundamentals of managing cutaneous melanoma are being neglected. A recent Australian study showed that doctors perform poorly in key aspects of managing this aggressive tumour.2 Only a …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL